诺华制药 NVS 深 沪
等待开盘 07-30 09:30:00 美东时间
117.16
+0.980
+0.84%
华盛通- 最 高117.78
- 今 开116.69
- 成交量 57.73万股
- 最 低 116.47
- 昨 收 116.18
- 总市值 2313.91亿
- 52周最高 124.8299
- 市盈率 静 19.98
- 换手率 0.03%
- 52周最低 92.7849
- 委 比 94.74%
- 总股本 19.75亿
- 历史最高 124.8299
- 量 比 0.58
- 振 幅 1.13%
- 历史最低 6.9614
- 每 手 1
- 风险率 7.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多EU pharma lobby criticizes potential Trump tariffs on pharmaceuticals
An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product ...
07-29 22:23
Incyte Projects 2025 Jakafi net product revenues Of $3B-$3.05B Compared To Prior Guidance Of $2.95B-$3B
2025 Financial GuidanceIncyte's guidance for the fiscal year 2025 is summarized below. Incyte is raising its revenue guidance for Jakafi to account for higher demand in the first half of 2025. Incyte is also raising its
07-29 19:04
中信证券：PCB正交背板充分契合AI服务器发展趋势 未来潜在市场空间有望打开
中信证券发布研报称，PCB正交背板作为解决AI算力集群中计算单元与网络单元间带宽瓶颈的潜在方案，在速率、集成度、散热、稳定性、布线等方面具备优势。由于其超大尺寸...
07-29 15:45
PCB正交背板如何打开2027-28年行业空间？
本文来自格隆汇专栏：中信证券研究 作者：徐涛 雷俊成 PCB正交背板作为解决AI算力集群中计算单元与网络单元间带宽瓶颈的潜在方案，在...
07-29 09:20
中信证券：PCB正交背板方案有望加速落地 具备技术实力PCB厂商有望优先受益
中信证券研报称，PCB正交背板作为解决AI算力集群中计算单元与网络单元间带宽瓶颈的潜在方案，在速率、集成度、散热、稳定性、布线等方面具备优势。由于其超大尺寸+超...
07-29 08:47
A Look at Incyte's Upcoming Earnings Report
Incyte (NASDAQ:INCY) is set to give its latest quarterly earnings report on Tue...
07-28 23:02
陈经：美国对华芯片制裁这招没用，撒手吧
【文/观察者网专栏作者 陈经】 中美芯片斗争，出现了一个有些意外的转折。 2025年7月15日，英伟达CEO黄仁勋接受央视记者采访时表示：“美国政府已经批准了我...
07-28 13:12
Nova Minerals Advises Permitting for the West Susitna Access Road to the Estelle Project Site has been Submitted
Nova Minerals Limited announced that the Alaska Industrial Development and Export Authority (AIDEA) has filed a permit application with the U.S. Army Corps of Engineers for the West Susitna Access Road. The 78.5-mile all-weather road, set to be developed in 2025-2026, will improve access to remote areas in Alaska, supporting resource development and enhancing economic opportunities. Governor Mike Dunleavy and local stakeholders have expressed str...
07-28 10:30
3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs
US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may not happen soon.
07-26 01:49
Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy
Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular dystrophy patients.
07-25 23:09
